Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907834431> ?p ?o ?g. }
- W2907834431 endingPage "1518" @default.
- W2907834431 startingPage "1510" @default.
- W2907834431 abstract "The outcomes of endovascular treatment of femoropopliteal atherosclerotic lesions have been improving recently. Although open repair is indicated for class D femoropopliteal lesions based on the TransAtlantic Inter-Society Consensus II (TASC II) document, in some cases, it is reasonable to use the endovascular approach for these lesions. The aim of this study was to retrospectively analyze the technical aspects and outcomes of treating TASC II D femoropopliteal disease with endovascular approaches.In total, 91 procedures between January 2011 and December 2016 were retrospectively analyzed. We collected data corresponding to the technical aspects and outcomes of treatment from an electronic database. Images and videos of all procedures were reviewed. Among the 91 procedures, 70 were for popliteal artery occlusions involving the trifurcation vessels, and 12 were for superficial femoral artery (SFA) occlusions of >20 cm in length; 9 procedures for occlusions meeting both criteria were also performed. The χ2 test was employed for statistical analyses, and logistic regression analyses were conducted to identify risk factors. Patency, wound healing, and survival were analyzed using the Kaplan-Meier method. Statistical significance was considered at P < .05.Approximately 44.4% of all patients were male. The mean age was 67.3 ± 20.7 years. Hypertension, diabetes, current smoker, kidney impairment, coronary disease, and cardiac insufficiency were identified in 92.3%, 66.6%, 21.7%, 7.6%, 25.6%, and 62.8% of the patients, respectively. All included patients had critical limb ischemia (11.5%, 84.6%, and 3.8% of cases corresponding to Rutherford categories 4, 5, and 6, respectively). Technical failure was observed in three patients (3.3%). The mean number of stents used was 0.7 ± 0.65 per patient. Primary patency at 30 days, 1 year, 2 years, and 3 years was 91%, 60.1%, 55.7%, and 50.6%, respectively. Limb salvage at 30 days, 1 year, 2 years, 3 years, and 4 years was 95.2%, 82.2%, 76.9%, 71.8%, and 63.7%, respectively. Reinterventions were necessary in 11.1% of the patients. Comparison of curves revealed significant differences in the 60-day primary patency for the SFA and popliteal groups (standard error, <10%; log-rank, P = .039). Analysis of the risk and technical factors affecting primary patency, limb salvage, and overall survival indicated that female sex was associated with poor survival (odds ratio, 8.942; 95% confidence interval, 1.105-72.36) and that the use of stents was associated with high rates of limb loss in the popliteal group (log-rank, P = .033).For endovascular treatment of TASC II D femoropopliteal lesions, primary patency was better in patients with popliteal artery occlusions involving the trifurcation vessels than in those with SFA occlusions >20 cm in length. Female sex was associated with the risk of major amputations, and the use of stents in patients with popliteal occlusions was associated with major limb loss." @default.
- W2907834431 created "2019-01-11" @default.
- W2907834431 creator A5023684505 @default.
- W2907834431 creator A5049845941 @default.
- W2907834431 creator A5060318415 @default.
- W2907834431 creator A5067461236 @default.
- W2907834431 creator A5080066478 @default.
- W2907834431 creator A5084446855 @default.
- W2907834431 date "2019-05-01" @default.
- W2907834431 modified "2023-10-06" @default.
- W2907834431 title "Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia" @default.
- W2907834431 cites W1040370884 @default.
- W2907834431 cites W129589342 @default.
- W2907834431 cites W1749532878 @default.
- W2907834431 cites W2025119733 @default.
- W2907834431 cites W2047371146 @default.
- W2907834431 cites W2063030984 @default.
- W2907834431 cites W2080166217 @default.
- W2907834431 cites W2080560153 @default.
- W2907834431 cites W2082768122 @default.
- W2907834431 cites W2101211648 @default.
- W2907834431 cites W2116086363 @default.
- W2907834431 cites W2119224839 @default.
- W2907834431 cites W2132326230 @default.
- W2907834431 cites W2156725441 @default.
- W2907834431 cites W2179022807 @default.
- W2907834431 cites W2301779543 @default.
- W2907834431 cites W2467122689 @default.
- W2907834431 cites W2521177852 @default.
- W2907834431 cites W2551988254 @default.
- W2907834431 cites W2606637726 @default.
- W2907834431 cites W2759106628 @default.
- W2907834431 cites W2888045096 @default.
- W2907834431 cites W4236938366 @default.
- W2907834431 doi "https://doi.org/10.1016/j.jvs.2018.08.176" @default.
- W2907834431 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30611581" @default.
- W2907834431 hasPublicationYear "2019" @default.
- W2907834431 type Work @default.
- W2907834431 sameAs 2907834431 @default.
- W2907834431 citedByCount "10" @default.
- W2907834431 countsByYear W29078344312020 @default.
- W2907834431 countsByYear W29078344312021 @default.
- W2907834431 countsByYear W29078344312023 @default.
- W2907834431 crossrefType "journal-article" @default.
- W2907834431 hasAuthorship W2907834431A5023684505 @default.
- W2907834431 hasAuthorship W2907834431A5049845941 @default.
- W2907834431 hasAuthorship W2907834431A5060318415 @default.
- W2907834431 hasAuthorship W2907834431A5067461236 @default.
- W2907834431 hasAuthorship W2907834431A5080066478 @default.
- W2907834431 hasAuthorship W2907834431A5084446855 @default.
- W2907834431 hasBestOaLocation W29078344311 @default.
- W2907834431 hasConcept C126322002 @default.
- W2907834431 hasConcept C126838900 @default.
- W2907834431 hasConcept C134018914 @default.
- W2907834431 hasConcept C141071460 @default.
- W2907834431 hasConcept C151956035 @default.
- W2907834431 hasConcept C2776098176 @default.
- W2907834431 hasConcept C2776820930 @default.
- W2907834431 hasConcept C2777303625 @default.
- W2907834431 hasConcept C2777466421 @default.
- W2907834431 hasConcept C2778213512 @default.
- W2907834431 hasConcept C2778653478 @default.
- W2907834431 hasConcept C2779723990 @default.
- W2907834431 hasConcept C2781099653 @default.
- W2907834431 hasConcept C2993278247 @default.
- W2907834431 hasConcept C3018348675 @default.
- W2907834431 hasConcept C3018386432 @default.
- W2907834431 hasConcept C555293320 @default.
- W2907834431 hasConcept C65409693 @default.
- W2907834431 hasConcept C71924100 @default.
- W2907834431 hasConceptScore W2907834431C126322002 @default.
- W2907834431 hasConceptScore W2907834431C126838900 @default.
- W2907834431 hasConceptScore W2907834431C134018914 @default.
- W2907834431 hasConceptScore W2907834431C141071460 @default.
- W2907834431 hasConceptScore W2907834431C151956035 @default.
- W2907834431 hasConceptScore W2907834431C2776098176 @default.
- W2907834431 hasConceptScore W2907834431C2776820930 @default.
- W2907834431 hasConceptScore W2907834431C2777303625 @default.
- W2907834431 hasConceptScore W2907834431C2777466421 @default.
- W2907834431 hasConceptScore W2907834431C2778213512 @default.
- W2907834431 hasConceptScore W2907834431C2778653478 @default.
- W2907834431 hasConceptScore W2907834431C2779723990 @default.
- W2907834431 hasConceptScore W2907834431C2781099653 @default.
- W2907834431 hasConceptScore W2907834431C2993278247 @default.
- W2907834431 hasConceptScore W2907834431C3018348675 @default.
- W2907834431 hasConceptScore W2907834431C3018386432 @default.
- W2907834431 hasConceptScore W2907834431C555293320 @default.
- W2907834431 hasConceptScore W2907834431C65409693 @default.
- W2907834431 hasConceptScore W2907834431C71924100 @default.
- W2907834431 hasIssue "5" @default.
- W2907834431 hasLocation W29078344311 @default.
- W2907834431 hasLocation W29078344312 @default.
- W2907834431 hasOpenAccess W2907834431 @default.
- W2907834431 hasPrimaryLocation W29078344311 @default.
- W2907834431 hasRelatedWork W2145032415 @default.
- W2907834431 hasRelatedWork W2600483242 @default.
- W2907834431 hasRelatedWork W2985603160 @default.
- W2907834431 hasRelatedWork W3127142931 @default.